(Rac)-AAA

1 Cited Publications
Kundenbewertung

Based on 1 publication(s) in Google Scholar

(Rac)-AAA is a regulator and inhibitor targeting GPR75. By blocking the 20-HETE-induced downregulation of GPR75 expression, (Rac)-AAA effectively inhibits the activation of key downstream signaling pathways including EGFR, AKT, NF-κB and FAK. (Rac)-AAA reverses 20-HETE-mediated epithelial-mesenchymal transition, which is specifically characterized by downregulating vimentin (vimentin), upregulating E-Cadherin, as well as reducing MMP-2 activity and cancer cell migration ability. (Rac)-AAA also abolishes the 20-HETE-induced upregulation of HIC-5 expression and anchorage-independent growth, and modulates the subcellular localization of PKC-α and phosphorylated AKT. (Rac)-AAA is investigated in androgen-independent prostate cancer (castration-resistant prostate cancer).

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • CAS. Nr.: 3055022-23-3
  • Formel: C24H39NNa2O6
  • Molecular Weight:483.55
  • Speicherung:
    Powder   -20°C, 3 years ; In solvent   -80°C, 6 months , -20°C, 1 month
  • Biologische Aktivität
  • Chemical Information
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) (Rac)-AAA

More

Alle MMP Isoform-spezifische Produkte anzeigen

More

Alle Akt Isoform-spezifische Produkte anzeigen

More

Alle ERK Isoform-spezifische Produkte anzeigen

More

Alle NF-κB Isoform-spezifische Produkte anzeigen

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00